HNN3.0
Register
Register
Register

Project cooperationUpdated on 21 January 2026

Human Collagen and Xeno-free Human ECM for Medical Applications

CEO at Arrakis Bio

Modi'in, Israel

About

Arrakis Bio developed a biomanufacturing platform for producing animal-free Human ECM and Human Collagen, based on human cells in a proprietary bio-reactor system that ensures consistent quality, reproducibility and scalability.

Application areas include - implantable medical devices, drug discovery platforms based on in-vitro NAMs, 3D bioprinting, Tissue regeneration (Bone, Skin, Tendon, Cartilage, etc), Cell therapy, drug delivery, and more.

Topic

  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine

Type

  • Partner seeks Consortium/Coordinator

Organisation

Arrakis Bio

Start-up

Modi'in, Israel

Similar opportunities

  • Project cooperation

    3D-Bioprinted Scaffolds for Drug Delivery & Tissue Regeneration Partnership

    • Consortium/Coordinator seeks Partners
    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

    Sema Bayraktar

    Research and Development Scientist at BlooCell

    Istanbul, Türkiye

  • Project cooperation

    Seeking Consortia & Expertise Offer for Tool-02 & Tool-03 (Bioprinting Projects)

    • Partner seeks Consortium/Coordinator
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing

    Hazal Evecen

    Business Development Specialist at Galata Innovation

    İstanbul, Türkiye

  • Project cooperation

    Biotech looking for collaboration partners: Cell therapy and cell-derived products

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

    Moayed Hamza

    CEO & Founder at HAON Life Science

    Dublin, Ireland